Corvus Pharmaceuticals (CRVS) PT Raised to $32 at Oppenheimer
Tweet Send to a Friend
(Updated - January 20, 2026 6:09 PM EST)
Oppenheimer analyst Jeff Jones raised the price target on Corvus Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones raised the price target on Corvus Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
